Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-1 of 1

Sort by

Sort Order Select

Journal Articles

RR6 prognostic model provides information about survival for myelofibrosis treated with ruxolitinib: validation in a real-life cohort

Emilia Scalzulli, Claudia Ielo, Cristina Luise, Paolo Musiu, Maria L. Bisegna, Ida Carmosino, Giovanni M. Assanto, Maurizio Martelli, Massimo Breccia

Blood Adv (2022) 6 (15): 4424–4426.

https://doi.org/10.1182/bloodadvances.2022008158

Published: 2022